drugset / Trial / NCT04427956

Corneal Crosslinking Treatment Study

NCT04427956

Phase 4 Completed 54 enrolled Region Skane
RandomizedParallel-groupOpen-labelTreatment

Summary

Three different protocols for inducing corneal crosslinks in subjets with progressive keratoconus will be evaluated in this randomised clinical study.

Timeline

Start
2017-05-23
Primary completion
2024-11-19
Completion
2024-11-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riboflavin Other / unclassified

Indications